12/2
08:27 am
icu
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI
Medium
Report
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI
11/20
09:52 am
icu
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference
Medium
Report
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference
11/17
08:43 am
icu
SeaStar Medical Announces Appointment of Michael Messinger as CFO
High
Report
SeaStar Medical Announces Appointment of Michael Messinger as CFO
11/5
10:03 am
icu
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
Medium
Report
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
9/29
08:36 am
icu
SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
Neutral
Report
SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
9/24
04:22 pm
icu
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
High
Report
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
9/23
08:23 am
icu
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
Medium
Report
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children